Advanced-Stage Primary Cutaneous T-Cell Lymphoma Treated with Bexarotene and Denileukin Diftitox

Advanced-stage primary cutaneous T-cell lymphoma has an unfavorable prognosis and low survival rates. Aggressive treatment with chemotherapy is not curative and causes considerable side effects. The combination of bexarotene and denileukin diftitox is associated with an acceptable safety profile and...

Descripción completa

Detalles Bibliográficos
Autores principales: Cervigón-González, Iván, Torres-Iglesias, Luis Miguel, Palomo-Arellano, Ángel, Gil-Pascual, Braulio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2011
Materias:
Published: February 2011
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3175357/
https://www.ncbi.nlm.nih.gov/pubmed/21931572
http://dx.doi.org/10.1159/000324185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3175357/
https://www.ncbi.nlm.nih.gov/pubmed/21931572
http://dx.doi.org/10.1159/000324185

Ejemplares similares